New York, NY – December 28, 2018 – North American Cannabis Holdings, Inc. (USOTC:USMJ), Puration, Inc. (USOTC: PURA), Kali, Inc. (USOTC: KALY) and Medical Marijuana, Inc. (USOTC: MJNA) have all been rated BULLISH by Stock Technical Analysis (Stockta.com). The cannabis sector, particularly companies with a strong hemp related presence, have seen increased investment interest since President Trump signed the Farm Act into law legalizing hemp farming.
PURA, In fact, has been rated VERY BULLISH having established a substantial support base at $0.08 after pulling back from a 52-week high of $0.25 and now showing signs of rebounding to its $0.25 52-week high.
USMJ has recently broken out on high volume. The PPS has made a dramatic move above $0.001. The 52-week high is $0.0025. The company has recently announced a $10 million revenue goal for 2019 based on its new ecommerce business. The company has also announced a pending dividend. With a positive cannabis market and progress toward the $10 million revenue goal, the USMJ PPS has the potential to break above $0.01.
KALY has recently acquired a patented cannabis extraction process changing its entire business. The company has announced $400,000 in contracts since making the acquisition. The company has also released pre-clinical research on cannabis extracts from its patented process conducted in partnership with universities. KALY is trading in the $0.02 to $0.03 range and a PPS of $0.10 would not be a surprise.
MJNA is also rated VERY BULLISH with a PPS currently trading at $0.08 with a 52 week high of $0.18. With the positive cannabis sector environment resulting from the recent passage of the Farm Act combined with MJNA’s steady business plan, MJNA seems set for a rebound to it $0.18 52-week high.
NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.